We could not find any results for:
Make sure your spelling is correct or try broadening your search.
RenovoRx Inc is a clinical-stage biopharmaceutical company. It is focused on developing therapies for the local treatment of solid tumors and conducting a Phase 3 registrational trial for lead product candidate RenovoGem. RenovoRx Inc is a clinical-stage biopharmaceutical company. It is focused on developing therapies for the local treatment of solid tumors and conducting a Phase 3 registrational trial for lead product candidate RenovoGem.
With $17.2 million in gross proceeds raised since the beginning of 2024, RenovoRx is well positioned to advance its pivotal Phase III clinical trial, expand development pipeline into additional...
Data shows that the Trans-Arterial Micro-Perfusion (TAMP) platform increases intra-arterial pressure, improving drug delivery with 100-fold increase local tissue concentration of the therapy TAMP...
RenovoRx, Inc. (βRenovoRxβ or the βCompanyβ) (Nasdaq: RNXT), a clinical-stage biopharmaceutical company developing novel precision oncology therapies based on a local drug-delivery platform...
Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | -0.07 | -5.73770491803 | 1.22 | 1.31 | 1.11 | 19237 | 1.18204764 | CS |
4 | -0.12 | -9.44881889764 | 1.27 | 1.48 | 1.11 | 22510 | 1.32009781 | CS |
12 | -0.56 | -32.7485380117 | 1.71 | 1.8201 | 1.1 | 35312 | 1.23759533 | CS |
26 | 0.5 | 76.9230769231 | 0.65 | 2.35 | 0.5306 | 67052 | 1.44350803 | CS |
52 | -0.88 | -43.3497536946 | 2.03 | 3.29 | 0.5306 | 189556 | 2.2030074 | CS |
156 | -7.1 | -86.0606060606 | 8.25 | 16.74 | 0.5306 | 451479 | 7.72685593 | CS |
260 | -7.1 | -86.0606060606 | 8.25 | 16.74 | 0.5306 | 451479 | 7.72685593 | CS |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: 1-888-992-3836 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions